[1]朱宝琛,师 帅,王 欢,等.不同血压等级代谢综合征患者的血栓形成特征[J].新乡医学院学报,2016,33(7):613-615.[doi:10.7683/xxyxyxb.2016.07.017]
 ZHU Bao-chen,SHI Shuai,WANG Huan,et al.Thrombogenesis character of metabolic syndrome patients with different level of hypertension[J].Journal of Xinxiang Medical University,2016,33(7):613-615.[doi:10.7683/xxyxyxb.2016.07.017]
点击复制

不同血压等级代谢综合征患者的血栓形成特征
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
33
期数:
2016年7
页码:
613-615
栏目:
临床研究
出版日期:
2016-07-05

文章信息/Info

Title:
Thrombogenesis character of metabolic syndrome patients with different level of hypertension
作者:
朱宝琛1师 帅2王 欢2张菀桐2
(1.中国中医科学院西苑医院基础医学研究所,北京 100091;2.中国中医科学院广安门医院,北京 100053)
Author(s):
ZHU Bao-chen1SHI Shuai2WANG Huan2ZHANG Wan-tong2
(1.Institute of Basic Medical Sciences,Xiyuan Hospital,China Academy of Chinese Medical Science,Beijing 100091,China;2.Guang′anmen Hospital,China Academy of Chinese Medical Science,Beijing 100053,China)
关键词:
代谢综合征高血压分级血栓风险血栓弹力图
Keywords:
metabolic syndromehypertension degreethrobogenesis riskthrombelastogram
分类号:
R589
DOI:
10.7683/xxyxyxb.2016.07.017
文献标志码:
A
摘要:
目的 运用不同的凝血功能检测方法评价代谢综合征合并不同等级高血压患者的血栓形成风险,从而指导临床用药。方法 将169例代谢综合征患者分为高血压1级组(MS1组)48例、高血压2级组(MS2组)39例、高血压3级组(MS3组)42例和非高血压组(MS0组)40 例,对4组患者分别进行凝血功能检测、血小板参数分析以及血栓弹力图参数检验,并进行比较,判断代谢综合征合并不同等级高血压患者的血栓形成风险。结果 MS0组患者组间血凝块形成时间(K)、最大振幅(MA)确定后30 min内血凝块幅度减少速率(LY30)高于MS1组、MS2组和MS3组(P<0.05);MS0组患者描记图最大曲线弧度作切线与水平线的夹角(Angle)低于MS1组、MS2组和MS3组(P<0.05),MS1组患者Angle值低于MS3组(P<0.05);MS0组、MS1组、MS2组、MS3组患者MA值依次升高,两两比较差异均有统计学意义(P<0.05);MS0组患者预测在MA确定后30 min内血凝块将要溶解百分数高于MS1组、MS2组和MS3组(P<0.05);MS0组、MS1组、MS2组、MS3组患者凝血反应时间两两比较差异无统计学意义(P>0.05)。MS0组、MS1组、MS2组患者血浆纤维蛋白原均低于MS3组(P<0.05);MS0组患者血小板(PLT)计数低于MS2组和MS3组(P<0.05),MS1组患者PLT计数低于MS3组(P<0.05);各组患者凝血酶原时间、活化部分凝血活酶时间、国际标准化比值、血小板体积分布宽度、平均血小板体积及大血小板比率比较差异无统计学意义(P>0.05)。结论 代谢综合征合并高血压患者具有较高的血栓形成风险,其风险值随血压等级的升高而升高,对于代谢综合征患者,应积极控制血压,预防血栓事件的发生。
Abstract:
Objective To discuss thrombogenesis risk in metabolic syndrome (MS) patients with different level of hypertension by detecting coagulation function with different method in order to give advisement for clinical treatment.Methods One hundred and sixty-nine patients were chosen and divided into MS with first level hypertension group(MS1 group,n=48),MS with second lever hypertension (MS2 group,n=39),MS with third hypertension (MS3 group,n=42) and MS with non-hypertension(MS0 group,n=40).The coagulation function,platelet parameter thrombelastogram were detected in the four groups and the results were compared to evaluate the thrombogenesis risk of MS patients with different level of hypertension.Results The levels of K and LY30 in MS0 group were higher than those in MS1 group,MS2 group and MS3 group(P<0.05).The level of Angle in MS0 group was lower than that in MS1 group,MS2 group and MS3 group(P<0.05),and the level of Angle in MS1 group was lower than that in MS3 group(P<0.05).The level of maximum amplitude(MA) in MS0 group,MS1 group,MS2 group,MS3 group increased in order,and there was significant difference of it comparison between any two groups(P<0.05).The level of estimate percent lysis in MS0 group was higher than that in MS1 group,MS2 group and MS3 group(P<0.05).There was no significant difference of R comparison between any two groups(P>0.05).The level of fibrinogen in MS0 group,MS1 group and MS2 group was lower than that in MS3 group(P<0.05).The level of platelet in MS0 group was lower than that in MS2 group and MS3 group(P<0.05);and it was lower in MS1 group compared with MS3 group(P<0.05).There was no significant difference in prothrombin time,activated partial thromboplastin time,international normalized ratio,platelet distribution width,mean platelet volume and platelet-large cell rate among the four groups(P>0.05).Conclusion MS patients with of hypertension have a high risk of thrombogenesis and it is necessary to give effective treatment to control the blood pressure and reduce the incidence of throbogenesis.

参考文献/References:

[1] 徐成斌.代谢综合征[J].国外医学内分泌学分册,2005,25(1):3-6.
[2] 赵雅静,张雯.代谢综合征患者凝血纤溶系统功能的变化[J].疑难病杂志,2009(7):397-399.
[3] 中国成人血脂异常防治指南制定委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419.
[4] 中国高血压防治指南修订委员会.中国高血压防治指南 2010[J].中华心血管病杂志,2011,39(7):585.
[5] 丁世彬,张国富,吴卫东.环境内分泌干扰物与代谢综合征[J].新乡医学院学报,2015,32(2):101-106.
[6] 冯海霞,万燕萍.维生素D缺乏与儿童代谢综合征关系的研究现状[J].中华实用儿科临床杂志,2013,28(19):1514-1516.
[7] MUKAI Y,WANG C Y,RIKITAKE Y,et al.Phosphatilylinositol 3-ki-nase/protein kinase Akl negativity regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells[J].Am J Physiol Heart Cire Physiol,2007,292(4):1938-1942.
[8] 芦璐,宗俊学,高阳.血栓形成标志物与原发性高血压的关系[J].中华老年心脑血管病杂志,2005,7(4):230-232.
[9] 张菀桐,朱宝琛,褚瑜光,等.冠心病高脂血症患者的血栓弹力图参数变化及相关性[J].中国循证心血管医学杂志,2015,7(6):812-813,817.

相似文献/References:

[1]王淑红,金培印,可海霞,等.血清妊娠相关蛋白A水平对代谢综合征患者预后评价[J].新乡医学院学报,2008,25(06):605.
[2]可海霞,贾银明,韩勤甫,等.妊娠相关蛋白A及C-反应蛋白与代谢综合征的关系[J].新乡医学院学报,2008,25(01):071.
[3]丁世彬,张国富,吴卫东.环境内分泌干扰物与代谢综合征[J].新乡医学院学报,2015,32(02):101.[doi:10.7683/xxyxyxb.2015.02.003]
[4]欧阳华,王章元,崔桂梅.苓桂术甘汤治疗抗精神病药物所致代谢综合征疗效分析[J].新乡医学院学报,2017,34(12):1085.[doi:10.7683/xxyxyxb.2017.12.010]
 OU-YANG Hua,WANG Zhang-yuan,CUI Gui-mei.Curative effect analysis of Linggui Zhugan Decoction in the treatment of metabolic syndrome induced by antipsychotic drugs[J].Journal of Xinxiang Medical University,2017,34(7):1085.[doi:10.7683/xxyxyxb.2017.12.010]

更新日期/Last Update: 2016-07-05